Keeping Patients Safe & Never Giving Up on a Cure
Learn More

Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • Our History
    • COVID-19 Resources
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Caregivers
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Financial Aid
    • Resources →
      • Symptom Management Workbook
      • Guidelines for Patients: Pancreatic Cancer
      • Creating Your Health Care Team
      • A Virtual Advocate
      • Patient Tools
  • HOW YOU CAN HELP
    • You Can Help Funds
    • Host Your Own Event
    • Event Calendar
    • Get Inspired
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • Other Ways to Give →
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Shop AmazonSmile
      • Car Program
  • SEARCH
Home / News / Global Research Collaboration for Early Diagnosis

Global Research Collaboration for Early Diagnosis

Our 2018-19 Seed Grant Awardees are collaborating across the globe on early detection tests for pancreatic cancer

December 12, 2018

Currently, pancreatic cancer has the highest mortality rate of all major cancers with 74% of all patients losing their battle within the first year of diagnosis. There is clear evidence that earlier diagnosis leads to improved outcomes. In a global collaboration, two Seed Grant Awardees are working towards methods to detect pancreatic cancer in its earliest stages.

In the 2018-19 Seed Grant cycle, the Hirshberg Foundation has awarded grants to Gary Xiao, PhD at the Dalian University of Technology and David Wong, DMD, DMSc at UCLA. Both researchers are focused on techniques for early detection of pancreatic cancer.

Dr. Xiao’s work in China has shown that analyzing the type and amount of very small bits of RNA (called micro RNA, or miRNA for short) can detect early changes in a cell’s function suggestive of the development of pancreatic cancer, long before any symptoms appear. RNA is known as the “messenger molecule” responsible for translating DNA in our genes into proteins. Proteins are what actually accomplish most key tasks and process in our bodies, and miRNA regulates how much of the RNA actually becomes such proteins. Using miRNA would allow for the detection of pancreatic cancer in its earliest stages, with the possibility of better treatment options.

Across the globe at UCLA, Dr. Wong has been researching the KRAS gene, notorious for promoting cancer growth when mutated. His work has shown that specific mutations in a region (codon 12) of the KRAS gene can reliably predict the development of pancreatic cancer – in many instances before an actual tumor has become large enough to detect by any known imaging technique.

The awardees met on November 7, 2018 together with Dr. Bill Go, Chair of the Foundation’s Scientific Advisory Board, and Agi Hirshberg, to explore the translational and clinical synergy of these two projects. This collaboration would bring together two early detection methods in the fight against pancreatic cancer.

“If each of these excellent techniques used together can provide even better early detection than when used independently – which early signs suggest is possible – we will have made a major step forward in the fight to eliminate pancreatic cancer as the deadly threat it is now,” said Agi Hirshberg.

Filed Under: News, Research

Hirshberg Foundation Funds Study Focused on Pancreatic Cancer Patient & Caregiver Well-Being
Symposium Speaker Spotlight: Dr. Jeffrey Chen on Medicinal Cannabis and Cancer

Patient Support Resources

from the comfort of your home


Our Webinar Library »

We bring new meaning to the words
Never Give Up.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Contact Us